4//SEC Filing
Sarepta Therapeutics, Inc. 4
Accession 0001325812-14-000026
$SRPTCIK 0000873303operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:49 PM ET
Size
8.8 KB
Accession
0001325812-14-000026
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Incentive Stock Option (right to buy)
2014-02-28+3,444→ 3,444 totalExercise: $29.03Exp: 2024-02-28→ Common Stock (3,444 underlying) - Award
Non-Qualified Stock Option (right to buy)
2014-02-28+186,556→ 186,556 totalExercise: $29.03Exp: 2024-02-28→ Common Stock (186,556 underlying)
Holdings
- 28,078
Common Stock
Footnotes (3)
- [F1]Includes 800 shares acquired under the Sarepta Therapeutics, Inc. 2013 Employee Stock Purchase Plan on February 28, 2014.
- [F2]Reflects a transfer exempt under Rule 16a-12 since the date of the Reporting Persons last ownership report.
- [F3]This option is exercisable at the rate of 25% of the shares on the first anniversary of the date of grant and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on the fourth anniversary of the date of grant.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000873303
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:49 PM ET
- Size
- 8.8 KB